| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |